methylprednisolone acetate / Generic mfg.  >>  Phase 2
Welcome,         Profile    Billing    Logout  

35 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
methylprednisolone acetate / Generic mfg.
NCT02462252: Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome

Completed
2a
11
US
BL-8040, horse anti-thymocyte globulin (hATG), ATGAM, Methylprednisolone, Medrol, Solu-Medrol, Depo-Medrol, Cyclosporine, Sandimmune, Cyclosporine A
BioLineRx, Ltd.
Aplastic Anemia, Hypoplastic Myelodysplastic Syndrome
11/20
11/20
NCT01177371: High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma

Completed
2
13
US
busulfan, BSF, BU, Misulfan, Mitosan, Myeloleukon, Myelosan, cyclophosphamide, CPM, CTX, Cytoxan, Endoxan, Endoxana, Enduxan, allogeneic bone marrow transplantation, bone marrow therapy, allogeneic, bone marrow therapy, allogenic, transplantation, allogeneic bone marrow, transplantation, allogenic bone marrow, methylprednisolone, A-MethaPred, Depo-Medrol, Medrol, MePRDL, Solu-Medrol, Wyacort, methotrexate, Abitrexate, amethopterin, Folex, methylaminopterin, Mexate, MTX, cyclosporine, 27-400, ciclosporin, cyclosporin, cyclosporin A, CYSP, Sandimmune
Case Comprehensive Cancer Center
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With T(15;17)(q22;q12), Adult Acute Myeloid Leukemia With T(16;16)(p13;q22), Adult Acute Myeloid Leukemia With T(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Acute Promyelocytic Leukemia (M3), Adult Erythroleukemia (M6a), Adult Nasal Type Extranodal NK/T-cell Lymphoma, Adult Pure Erythroid Leukemia (M6b), Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Burkitt Lymphoma, Childhood Acute Erythroleukemia (M6), Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myeloid Leukemia in Remission, Childhood Acute Myelomonocytic Leukemia (M4), Childhood Acute Promyelocytic Leukemia (M3), Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, De Novo Myelodysplastic Syndromes, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Hepatosplenic T-cell Lymphoma, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Peripheral T-Cell Lymphoma, Post-transplant Lymphoproliferative Disorder, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult Non-Hodgkin Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Refractory Multiple Myeloma, Relapsing Chronic Myelogenous Leukemia, Secondary Myelodysplastic Syndromes, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Testicular Lymphoma, Waldenstrom Macroglobulinemia
02/00
02/10
NCT00004192: Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma

Completed
2
60
US
filgrastim, Neupogen, pegfilgrastim, Neulasta, cisplatin, chemotherapy drug, cytarabine, cytosine arabinoside, etoposide, Etopophos, Toposar, methylprednisolone, Depo-Medrol, Medrol, Solu-Medrol, P-Care D80, ReadySharp Methylprednisolone, and P-Care D40
University of Nebraska, National Cancer Institute (NCI)
Lymphoma, Neutropenia
02/01
03/01
NCT00002833: Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia

Completed
2
53
US
Filgrastim, G-CSF, Neupogen, Cladribine, Leustatin, 2-CdA, Cyclosporine, Sandimmune, CYA, Cyclosporin A, Cytarabine (Ara-C), Ara-C, Cytosar, DepoCyt, Cytosine Arabinosine Hydrochloride, Fludarabine Phosphate, Fludara, Fludarabine, Idarubicin, Idamycin, Methylprednisolone, Depo-Medrol, Medrol, Solu-Medrol, Peripheral Blood Stem Cell Transplantation, PBSCT, Stem Cell Transplant
M.D. Anderson Cancer Center, National Cancer Institute (NCI)
Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes
04/02
04/02
NCT00002524: Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma

Completed
2
46
US
Bleomycin Sulfate, Blenoxane, BLM, Filgrastim, G-CSF, Neupogen, Cisplatin, Platinol, Plationol-AQ, CDDP, Cyclophosphamide, Cytoxan, Neosar, Cytarabine, Ara-C, Cytosar, DepoCyt, Cytarabine arabinosine hydrochloride, Doxorubicin Hydrochloride (DOX), Adriamycin PFS, Adriamycin RDF, Etoposide, VePesid, Fluorouracil, 5-FU, Adrucil, Efudex, 5-Fluorouracil, Ifosfamide, Ifex, Leucovorin calcium, Citrovorum, Wellcovorin, Methotrexate, Methylprednisolone, Depo-Medrol, Medrol, Solu-Medrol, Pentamidine, Pentam-300, Prednisone, Trimethoprim-Sulfamethoxazole, SMX, Bactrim, Cotrim, Septra, Sulfamethoprim, Sulfatrim, Sulfoxaprim, Trisulfam, Uroplus, Co-trimoxazole, SMX-TMP, Vincristine Sulfate, Zidovudine (AZT), Retrovir, Radiation Therapy, RT, Radiotherapy
M.D. Anderson Cancer Center, National Cancer Institute (NCI)
Lymphoma
10/05
10/05
NCT00354172: Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers.

Terminated
2
16
US
aldesleukin, IL-2, interleukin-2, filgrastim, granulocyte colony-stimulating factor (G-CSF), natural killer cell (NK) therapy, NK cells, cyclophosphamide, Cytoxan, cyclosporine, cyclosporin, fludarabine phosphate, Fludara, methylprednisolone, Medrol, Solu-Medrol, Depo-Medrol, methylprednisolone sodium succinate, mycophenolate mofetil, mycophenolic acid, Umbilical Cord Blood Transplantation (UCBT), allogeneic transplant, Total body irradiation (TBI), radiation
Masonic Cancer Center, University of Minnesota
Leukemia, Myelodysplastic Syndromes
08/08
08/08
NCT00057811: Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma

Checkmark
Jun 2013 - Jun 2013: 
Checkmark P2 data in leukemia/lymphoma
Nov 2011 - Nov 2011: P2 data in leukemia/lymphoma
Completed
2
97
US
doxorubicin hydrochloride, ADM, ADR, Adria, Adriamycin PFS, Adriamycin RDF, cyclophosphamide, CPM, CTX, Cytoxan, Endoxan, Endoxana, methotrexate, amethopterin, Folex, methylaminopterin, Mexate, MTX, rasburicase, Elitek, NK-631, recombinant urate oxidase, leucovorin calcium, CF, CFR, LV, prednisone, DeCortin, Deltra, methylprednisolone, Depo-Medrol, Medrol, MePRDL, Solu-Medrol, Wyacort, filgrastim, G-CSF, Neupogen, rituximab, IDEC-C2B8, IDEC-C2B8 monoclonal antibody, Mabthera, MOAB IDEC-C2B8, Rituxan, cytarabine, ARA-C, arabinofuranosylcytosine, arabinosylcytosine, Cytosar-U, cytosine arabinoside, etoposide, EPEG, VP-16, VP-16-213, vincristine sulfate, leurocristine sulfate, VCR, Vincasar PFS, hydrocortisone sodium succinate, Sodium hydrocortisone succinate, Solu-Cortef, Solu-Glyc, laboratory biomarker analysis
Children's Oncology Group, National Cancer Institute (NCI)
Childhood Burkitt Lymphoma, Childhood Diffuse Large Cell Lymphoma, Childhood Immunoblastic Large Cell Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Untreated Childhood Acute Lymphoblastic Leukemia
10/09
07/14
NCT01205477: Safety and Efficacy of Methylprednisolone Infiltration in Anserine Bursitis Treatment

Completed
2
58
RoW
EXPERIMENTAL, DEPOMEDROL, PLACEBO
Universidad Autonoma de Nuevo Leon
Bursitis
07/10
07/10
NCT00186628: Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD

Completed
2
36
US
Total lymphoid irradiation, TLI, Rituximab, Rituxan, Anti-thymoglobulin, rabbit (ATG, rabbit ATG), Cyclosporine, CSP, Sandimmune, Mycophenylate mofetil, MMF, CellCept, Filgrastim, G-CSF, Granulocyte-colony stimulating factor, Neupogen, Granisetron, Sancuso, Solumedrol, Medrol, Depo-Medrol, A-Methapred, Acetaminophen, Tylenol, Diphenhydramine, Benadryl, Hydrocortisone, Westcort
Stanford University, The Leukemia and Lymphoma Society, National Cancer Institute (NCI)
Leukemia, Mast-Cell, Mantle-cell Lymphoma
11/10
12/10
NCT00185692: Allogeneic Transplantation From Related Haploidentical Donors

Completed
2
16
US
non-myeloablative hematopoietic cell transplantation, Peripheral-blood stem-cell transplantation, Anti-Thymocyte Globulin, ATG, Cyclosporine, INN/BAN, USAN, CSA, Mycophenolate Mofetil, MMF, CellCept, G-CSF, Granulocyte colony-stimulating factor, CSF 3, Solumedrol, 6-Methylprednisolone, Methylprednisolone Acetate, Methylprednisolone Sodium Succinate, Acetaminophen, Tylenol, Diphenydramine, Benadryl, Allermax, Q-Dryl, Diphen Cough, Hydrocortisone, Hydrocortisone Sodium Phosphate
Stanford University
Blood Cancer, Leukemia, Graft Versus Host Disease, Malignancy, CLL, NHL, Hodgkin's Disease, MDS
12/10
12/10
NCT00309907: Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant

Completed
2
39
US
etanercept, Enbrel, ETN, TNFR:Fc, Tumor Necrosis Factor Receptor IgG Chimera, methylprednisolone, Depo-Medrol, Medrol, MePRDL, Solu-Medrol, Wyacort
Children's Oncology Group, National Cancer Institute (NCI)
Accelerated Phase Chronic Myelogenous Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Chronic Phase Chronic Myelogenous Leukemia, de Novo Myelodysplastic Syndromes, Disseminated Neuroblastoma, Juvenile Myelomonocytic Leukemia, Previously Treated Childhood Rhabdomyosarcoma, Previously Treated Myelodysplastic Syndromes, Pulmonary Complications, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Neuroblastoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors, Recurrent/Refractory Childhood Hodgkin Lymphoma, Relapsing Chronic Myelogenous Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes
09/11
09/11
NCT01028313: A Study of Panobinostat (LBH589) as Second-Line Therapy in Patients With Chronic Graft-Versus-Host Disease

Withdrawn
2
0
US
LBH589, Panobinostat, Methylprednisolone, Medrol, Depo-Medrol
SCRI Development Innovations, LLC, Novartis
Chronic Graft-Versus-Host Disease
 
 
ENZON-OHSU-4913, NCT01005914: Pegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Terminated
2
11
US
cyclophosphamide, Cytoxan, Neosar, CTX, cytarabine, Cytosar-U, Ara-C, Arabinosylcytosine, dexamethasone, Decadron, DexPak, dex, doxorubicin hydrochloride, Adriamycin RDF, Adriamycin PFS, imatinib mesylate, Gleevec, Glivec, methotrexate, Trexall, Rheumatrex, MTX, methylprednisolone, Medrol, Depo-Medrol, Solu-Medrol, pegaspargase, Onscapar, PEG-L-asparaginase, vincristine sulfate, Marqibo
OHSU Knight Cancer Institute
Leukemia
03/13
05/14
2009-016650-40: Kan injektion af Methylprednisolonacetat (Depo-Medrol) 80 mg i mastektomikaviteten ved drænfjernelsen efter operation for primær mammakancer virke profylaktisk mod seromdannelse ?Et randomiseret projekt

Completed
2
205
Europe
Depo-Medrol, Concentrate for solution for injection, Depo-Medrol Pfizer
Herlev Hospital
Seromdannelsen efter mastektomi for primær brystkræft
 
 
NCT00671658: Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia

Completed
2
220
US
Rituximab, Rituxan, Cyclophosphamide (CTX), Cytoxan, Neosar, Doxorubicin, Adriamycin, Rubex, Vincristine, Oncovin, Vincasar Pfs, Dexamethasone, Decadron, Methotrexate (MTX), Rheumatrex, Cytarabine, Ara-C, Cytosar-U, Arabinosylcytosine, DepoCyt, G-CSF, Filgrastim, Neupogen, Mesna, Mesnex, Pegylated asparaginase, Pegaspargase, Oncaspar, Polyethylene Glycol Conjucated Lasparaginase-H, Pegfilgrastim, Neulasta, PEG-G-CSF, Solumedrol, Methylprednisolone, Depo-Medrol, Medrol
M.D. Anderson Cancer Center
Leukemia, Acute Lymphoblastic Leukemia
07/13
07/13
NCT01093586: Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Completed
2
14
US
double-unit umbilical cord blood transplantation, cytogenetic analysis, bone marrow aspiration, fluorescence in situ hybridization, fluorescence in situ hybridization (FISH), busulfan, BSF, BU, Misulfan, Mitosan, Myeloleukon, Myelosan, cyclophosphamide, CPM, CTX, Cytoxan, Endoxan, Endoxana, Enduxan, anti-thymocyte globulin, ATG, ATGAM, lymphocyte immune globulin, Thymoglobulin, methylprednisolone, A-MethaPred, Depo-Medrol, Medrol, MePRDL, Solu-Medrol, Wyacort, cyclosporine, 27-400, ciclosporin, cyclosporin, cyclosporin A, CYSP, Sandimmune, mycophenolate mofetil, Cellcept, MMF, flow cytometry, allogeneic hematopoietic stem cell transplantation
Case Comprehensive Cancer Center
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Erythroleukemia (M6a), Adult Nasal Type Extranodal NK/T-cell Lymphoma, Adult Pure Erythroid Leukemia (M6b), B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Burkitt Lymphoma, Childhood Acute Erythroleukemia (M6), Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Myelomonocytic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, de Novo Myelodysplastic Syndromes, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Juvenile Myelomonocytic Leukemia, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Previously Treated Myelodysplastic Syndromes, Prolymphocytic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Childhood Grade III Lymphomatoid Granulomatosis, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Relapsing Chronic Myelogenous Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Secondary Myelofibrosis, Splenic Marginal Zone Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia, T-cell Large Granular Lymphocyte Leukemia, Waldenstrom Macroglobulinemia
12/15
12/15
2007-007793-29: Efficacy of long acting steroids intramuscular therapy in nephrotic syndrome: pilot study.

Ongoing
2
29
Europe
DEPOMEDROL, DEPOMEDROL
ISTITUTO GIANNINA GASLINI
NEPHROSIC SYNDROME
 
 
NCT00609609: Photopheresis for the Treatment of Acute Graft Versus Host Disease

Completed
2
81
US
Photopheresis, Extracorporeal Photopheresis, ECP, Methylprednisolone, Medrol, Depo-Medrol, Solu-Medrol
M.D. Anderson Cancer Center, Mallinckrodt
Graft Versus Host Disease
01/16
01/16
NCT02253966: Preoperative Intraarticular Injection of Methylprednisolone in Patients Scheduled for Total Knee-arthroplasty

Completed
2
48
Europe
Methylprednisoloneacetate, Depo-Medrol, Lidocaine, sodium chloride, saline
Rigshospitalet, Denmark, Lundbeck Foundation
Knee Joint Osteoarthrosis, Hyperalgesia, Severe Movement Related Pain
03/16
03/16
2014-002744-40: Injection af glucocorticoid in the knee before total knee replacement surgery

Completed
2
48
Europe
Concentrate for solution for injection, Depo-medrol
Section For Surgical Pathophysiology, Rigshospitalet, The Lundbeck Foundation
Knee joint arthrosis with hyperalgesia and severe movement related pain, Arthrosis in the knee joint with severe pain and excessive pain response to normal stimuli, Diseases [C] - Musculoskeletal Diseases [C05]
 
 
NCT02294357: Weekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to 27 mg/m2 Carfilzomib

Terminated
2
45
US
Carfilzomib, Kyprolis, Dexamethasone, Decadron, Dexamethasone acetate, Prednisone, Deltasone, Cortan, Methylprednisolone, Medrol, Methylprednisolone acetate, Lenalidomide, Revlimid, Pomalidomide, Pomalyst
Oncotherapeutics, Amgen
Multiple Myeloma
09/20
09/20
NCT01319981: Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia

Completed
2
31
US
Rituximab, Rituxan, Imatinib, Imatinib Mesylate, Gleevec, ST1571, NSC-716051, Cyclophosphamide, Cytoxan, Neosar, Doxorubicin, Adriamycin, Rubex, Mesna, Mesnex, VSLI, Liposomal Vincristine, Vincristine Sulfate Liposomes Injection, Marqibo, Solu-Medrol, Methylprednisolone, Depo-Medrol, Medrol, Methotrexate, Ara-C, Cytarabine, Cytosar, DepoCyt, Cytosine Arabinosine Hydrochloride, G-CSF, Filgrastim, Neupogen, Pegfilgrastim, Neulasta, Dexamethasone, Decadron
M.D. Anderson Cancer Center, Spectrum Pharmaceuticals, Inc
Leukemia
11/20
11/20
NCT03913702: Subacromial Methylprednisolone Versus Ketorolac for Shoulder Impingement

Terminated
2
1
US
Ketorolac Tromethamine, Toradol, Methylprednisolone Acetate, DepoMedrol
The University of Texas Medical Branch, Galveston
Subacromial Impingement, Subacromial Impingement Syndrome
11/22
11/22
Yale SEVEN, NCT05279092: Yale Steroid Enhanced Versus Exparel Nerveblock TKA RCT Study

Recruiting
2
250
US
Bupivacaine-Liposomal Bupivacaine, Bupivacaine -Dexamethasone Sodium Phosphate-Methylprednisolone Acetate
Yale University, Department of Anesthesiology Faculty Development Fund
Total Knee Replacement, Knee Arthroplasty
03/25
03/26
Yale SEVEN, NCT05736549: Yale Steroid Enhanced Versus Exparel Nerveblock TKA Part 2

Recruiting
2
66
US
Bupivacaine-Liposomal Bupivacaine, B-LB, Bupivacaine -Dexamethasone Sodium Phosphate-Methylprednisolone Acetate, B-DEX-MPA
Yale University, Department of Anesthesiology Faculty Development Fund
Total Knee Replacement, Knee Arthroplasty
03/25
03/26
ECOG-ACRIN-EAQ172, NCT04438382: Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis

Terminated
2
1
US
Infliximab, Remicade, Intravenous Immunoglobulin Therapy, Gamma Globulin, Gamma Globulin Therapy, Immune Globulin, Immune Globulin Therapy, Intravenous Immunoglobulin, IVIG, Prednisone, Deltasone, Orasone, Meticorten, Panasol-S, Liquid-Pred, Methylprednisolone, Methylprednisolone sodium succinate (Solu-Medrol), methylprednisolone acetate (Depo-Medrol), Methylprednisolone (Medrol)
ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI)
Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Steroid-Refractory Pneumonitis
12/23
12/23
NCT00002831: Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia

Completed
1/2
24
US
Filgrastim, C-CSF, Neupogen, Busulfan, Busulfex, Myleran, Cyclophosphamide, Cytoxan, Neosar, Cyclosporine, Sandimmune, CYA, Cyclosporin A, Decitabine (DAC), Dacogen, Methotrexate, Methylprednisolone, Depo-Medrol, Medrol, Solu-Medrol, Tacrolimus, Prograf, Allogeneic Bone Marrow Transplantation, ABMT, Peripheral Blood Stem Cell Transplantation, PBSCT
M.D. Anderson Cancer Center, National Cancer Institute (NCI)
Leukemia
12/02
12/02
NCT00987831: Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE)

Completed
1/2
158
US
Group B SLE one blood donation, Blood drawing only Group C, Group A SLE prospective study, depomedrol, medrol, methylprednisolone
Oklahoma Medical Research Foundation, Pfizer
Systemic Lupus Erythematosus
12/12
12/12
NCT00968253: RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia

Completed
1/2
24
US
Everolimus (RAD001), Afinitor, Cyclophosphamide, Cytoxan, Neosar, Vincristine, Doxorubicin, Adriamycin, Rubex, Dexamethasone, Decadron, Mesna, Mesnex, Methotrexate, Ara-C (Cytarabine), Cytosar, DepoCyt, Cytosine Arabinosine Hydrochloride, Methylprednisone, Medrol, Depo-Medrol, Solu-Medrol, G-CSF, Filgrastim, Neupogen, Granulocyte Colony Stimulating Factor
M.D. Anderson Cancer Center, Novartis
Leukemia, Acute Lymphocytic Leukemia
12/15
12/15
TONTT, NCT01783847: Traumatic Optic Neuropathy Treatment Trial

Completed
1/2
117
RoW
Recombinant human erythropoietin (EPO), EPO (Pooyesh darou Co., Tehran), Observation, Methyl prednisolone, Depo-Medrol
Tehran University of Medical Sciences, Iran University of Medical Sciences, Mashhad University of Medical Sciences, Shahid Beheshti University of Medical Sciences
Traumatic Optic Neuropathy
04/16
02/17
2016-001850-16: Effects of glucocorticoids on human gut bacteria Effekten af glykokortikoid på tarmens bakteriesammensætning

Completed
1/2
60
Europe
Tablet, Injection, Prednisolon "DLF", Depo-Medrol
University of Copenhagen, The Novo Nordisk Foundation Center For Basic Metabolic Research, Section of Metabolic Genetic, University of Copenhagen, The Novo Nordisk Foundation Center For Basic Metabolic Research, section of Metabolic Genetic
Young healthy men Unge raske mænd, Young healthy men Unge raske mænd, Body processes [G] - Physiological processes [G07]
 
 
NCT01875237: Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene

Terminated
1/2
3
US
Fludarabine, Fludarabine phosphate, Fludara, Melphalan, Alkeran, Alemtuzumab, CAMPATH-1H, Campath, Stem Cell infusion, Tacrolimus, Prograf, Mini Methotrexate, G-CSF, Filgrastim, Neupogen, Donor Lymphocyte Infusion (DLI), AP1903, Methylprednisolone, Depo-Medrol, Medrol, Solu-Medrol, Questionnaire, Survey
M.D. Anderson Cancer Center, Bellicum Pharmaceuticals
Leukemia, Myeloma, Myeloproliferative Diseases
03/17
03/17
NCT02049073: Prevention of Noise-induced Hearing Loss

Withdrawn
1/2
0
US
Zonisamide, Zonegran, Methylprednisolone, Medrol, Solu-Medrol, Depo-Medrol, Hybrisil, A-Methapred
Washington University School of Medicine
Noise-induced Hearing Loss
11/17
11/17
NCT00787722: Hematopoietic Stem Cell Transplant in Devic's Disease

Completed
1/2
13
US
Hematopoietic Stem Cell Transplantation, Cyclophosphamide, Cytoxan, Neosar, G-CSF, Neupogen, Filgrastim, Granix, Zarxio, rATG, Thymoglobulin, Anti-Thymocyte Globulin, Mesna, Mesnex, Rituximab, Rituxan, Methylprednisolone, Solu-Medrol, Depo-Medrol
Northwestern University
Devic's Disease
11/18
11/18
NCT02464657: Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Completed
1/2
44
US
Nivolumab, BMS-936558, Opdivo, Idarubicin, Idamycin, Cytarabine, Ara-C, Cytosar, DepoCyt, Cytosine Arabinosine Hydrochloride, Solu-medrol, Methylprednisolone, Depo-Medrol, Medrol, Dexamethasone, Decadron
M.D. Anderson Cancer Center, Bristol-Myers Squibb
Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome
05/20
05/20

Download Options